Short Interest in SciSparc Ltd. (NASDAQ:SPRC) Drops By 42.2%

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a significant drop in short interest in the month of March. As of March 13th, there was short interest totaling 84,388 shares, a drop of 42.2% from the February 26th total of 145,932 shares. Based on an average daily trading volume, of 443,124 shares, the short-interest ratio is currently 0.2 days. Approximately 21.5% of the shares of the company are sold short.

SciSparc Price Performance

Shares of SPRC opened at $3.97 on Friday. The firm has a fifty day moving average of $5.84 and a 200-day moving average of $18.24. SciSparc has a 1 year low of $3.60 and a 1 year high of $94.50.

SciSparc Company Profile

SciSparc AG is a clinical‐stage medical technology company focused on the development and commercialization of extracorporeal shock wave–based neuromodulation devices. Founded in 2016 and headquartered in Switzerland, the company applies proprietary low‐intensity shock wave technology to noninvasively stimulate neural tissue. SciSparc completed its initial public offering on the NASDAQ in 2021 under the ticker SPRC, securing funding to advance its clinical pipeline.

The company’s lead product, the TR100 system, delivers transcranial shock wave stimulation (tSWS) designed to target areas of the brain associated with motor control and cognitive function.